Today: 9 June 2026
IBM Stock Soars on AI, Quantum, and Cloud Hype – Is the Rally Sustainable?

AI & Quantum Sparks a Big Blue Comeback – IBM Stock Rallies (But Will it Last?)

  • Price Jump: IBM shares closed near $308 on Oct. 29, 2025, up roughly 30% year-to-date. The stock hit multi-year highs (around $307–310) in late October on investor excitement over AI and quantum breakthroughs.
  • Recent Catalysts: In October IBM unveiled a flurry of AI/cloud deals – an AMD-powered AI supercomputer for startup Zyphra, integration of Anthropic’s Claude AI into IBM tools, a Bharti Airtel cloud partnership in India, new Oracle-AI agents on its platform, and an Nvidia/Groq chip tie-upts2.techts2.tech. On Oct. 24 Reuters reported IBM’s researchers ran a quantum error-correction algorithm on a standard AMD chip – “10× faster than what is needed,” as IBM’s Jay Gambetta put it – spurring a ~7.9% stock jump that dayts2.techreuters.com.
  • Q3 Results: IBM’s July–Sept. 2025 earnings (reported Oct. 22) beat Wall Street estimatests2.tech. Revenue was $16.33 billion (versus $16.09 B consensus) and adjusted EPS $2.65 (vs. $2.44)ts2.tech. The company raised full-year revenue guidance to “more than 5%” growthts2.tech. High-margin segments drove the beat: sales of AI-optimized mainframes jumped 17% to $3.56 Bts2.tech, and IBM’s total AI-related “book” hit $9.5 B (up $2 B from Q2)ts2.techts2.tech. Management noted the new AMD-enhanced mainframe is in heavy demand in finance and regulated industries.
  • Mixed Signals: Cloud/Red Hat software growth slowed. Q3 Red Hat revenue rose only ~14% (vs. 16% in Q2)ts2.tech, and legacy transaction-processing software fell 1%ts2.tech. This deceleration spooked investors: IBM stock fell ~5% in after-hours trading on Oct. 22ts2.tech. As one analyst (Running Point’s Michael Schulman) warned, “a slowdown in Red Hat revenue … will disappoint some”ts2.tech. Synovus Trust’s Dan Morgan quipped that after recent gains “the stock is priced to perfection…there’s just not a lot of room to miss” on any metricsts2.tech.

Image: The IBM logo has been prominently displayed at tech conferences as Big Blue pushes its new AI/cloud and quantum initiatives (Sources: Reuters, IBM).

Valuation & Dividends: IBM now trades at tech-like multiples – forward P/E in the mid-20s, well above its historical ~16×. The company boasts strong cash flow and a dividend yielding ~2.3%. IBM is a Dividend Aristocrat with 29 years of consecutive raises, which helps cushion concerns over valuation.

Analyst Outlook: Wall Street is cautiously optimistic. Roughly half of analysts rate IBM a “Buy,” but the consensus is nearer Hold/Neutral, with a 12-month price target around $280–286ts2.techts2.tech (just below recent prices). Targets range widely. Bullish firms (Goldman Sachs: $350; Wedbush: $325; Bank of America: ~$310) cite IBM’s AI/cloud pivot as justificationts2.tech. Skeptical voices are nearer $250-$280: Bernstein’s Toni Sacconaghi and others (and even Morgan Stanley’s $256 targetts2.tech) note that IBM still lags faster-growing tech peers. Evercore ISI highlights that IBM’s huge balance sheet and M&A pipeline (e.g. integrating last year’s HashiCorp buy) is an “underappreciated lever” that could spark valuereuters.com. In short, analysts now bake in only mid-single-digit revenue growth for 2026, implying limited upside. One portfolio manager warns that after this rally, “there’s just not a lot of room to miss” on future resultsts2.tech.

IBM vs. Tech Titans

IBM’s comeback has been fueled by enterprise AI and cloud efforts, but its core business is much smaller than the hyperscalers’. For comparison, Microsoft’s Azure cloud grew ~40% in the September quarter, and Microsoft’s stock is up nearly 30% YTD. Google’s cloud grew ~30% and Amazon Web Services ~18%. By contrast, IBM’s hybrid-cloud software growth (Red Hat) is in the mid-teens. IBM competes on niche strengths – secure mainframes, industry consulting, and on-prem/cloud integration – rather than public-cloud scale. For now it is riding the AI wave in enterprise IT. (Oracle – another IBM peer – similarly touts AI value to investors.)

In the broader market, tech stocks have been on a tear: the Nasdaq and S&P have hit records on AI optimism, with chipmaker Nvidia recently nearing a $5 trillion market capreuters.com. The S&P 500 is up about 17% YTDreuters.com. However, commentators warn of an “AI bubble” risk if spending is too high or results underwhelm. IBM’s rally reflects this trend, but also exposes it: as one strategist puts it, IBM is now being valued more like a high-growth tech namets2.tech.

What’s Next

Investors will watch IBM’s next catalysts closely. The key tests will be execution on its AI/cloud roadmap and whether Red Hat/hybrid-cloud growth re-accelerates. The Q4 2025 earnings (mid-Jan 2026) and any new AI/quantum announcements will be scrutinized. Many analysts expect IBM’s business to see only modest growth (~3–5% annually) under current plans. In other words, with IBM trading in the $300s, the market expects good news: any slowdown could trigger a pullback. On the upside, if IBM delivers and capitalizes on its recent wins, bulls argue the stock could climb into the mid-$300s.

Sources: IBM’s 2025 filings and press releases; Reuters, Bloomberg, CNBC and TechStock² (ts2.tech) analysis.

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears
Previous Story

Chinese EV Tsunami Shakes German Auto Industry: BYD’s 30% Profit Crash and ‘Electrobomber’ Fears

eBay Stock Soars on Earnings Beat, Stumbles on Weak Holiday Outlook
Next Story

eBay Stock Soars on Earnings Beat, Stumbles on Weak Holiday Outlook

Go toTop